Centralized Data Exchange for Diabetes Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diabetes management systems lack a unified platform that can seamlessly integrate and utilize data from various monitoring techniques, such as self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM), to provide scalable monitoring and treatment strategies, including real-time automated closed-loop control, which is essential for maintaining glycemic control without increasing the risk of hypoglycemia.
Innovation Solution
The Diabetes Assistant (DiAs) platform, a flexible system that aggregates data from diverse blood glucose measurement and insulin delivery devices, uses a modular architecture to classify and process data, determining patient risk and providing advisory messages and control signals through a Body Sensor Network, enabling informed glycemic control at multiple levels, from long-term trends to real-time automated control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple separate monitoring and control systems are used (SMBG, CGM, insulin pumps), then each system can be optimized independently, but the overall system complexity increases and data integration becomes difficult
Solution Approach 1:
The patent combines multiple separate monitoring and control systems (SMBG meters, CGM devices, insulin pumps) into a unified data exchange system. The centralized server aggregates data from all these devices through standardized interfaces, enabling integrated analysis and coordinated control decisions, thereby resolving the complexity of managing multiple independent systems while maintaining their individual optimization
Solution Approach 2:
The centralized server acts as a universal platform that can receive, process, and analyze data from various types of glucose monitoring devices and insulin delivery systems. It provides multi-functional capabilities including data aggregation, risk assessment, treatment recommendation, and automated control, making it adaptable to different device configurations and patient needs
2Measurement precision
If comprehensive data from multiple sources is collected and analyzed, then more accurate risk assessment and treatment decisions can be made, but the data processing complexity and computational requirements increase
Solution Approach 1:
The data processing system is segmented into modular components: data aggregation module, risk assessment module, treatment recommendation module, and automated control module. Each module handles specific aspects of data processing independently, reducing overall complexity while enabling comprehensive analysis. The segmentation allows parallel processing and facilitates targeted optimization of each processing stage
3Productivity
If automated closed-loop control is implemented, then real-time glycemic control improves, but the risk of hypoglycemia and system failures increases
Solution Approach 1:
The system implements multi-layered feedback mechanisms: continuous glucose monitoring provides real-time feedback on glycemic status, risk assessment algorithms provide feedback on potential hypoglycemic events, and automated control adjustments provide feedback on treatment effectiveness. This layered feedback enables the system to detect and respond to changing conditions, reducing hypoglycemia risk while maintaining control efficiency
Solution Approach 2:
The system employs predictive risk assessment algorithms that identify potential hypoglycemic events before they occur. By detecting risk patterns in advance, the system can proactively adjust insulin delivery or alert the patient, cushioning against the harmful effects of hypoglycemia before they manifest. This prior cushioning approach reduces the actual occurrence and severity of hypoglycemic events
Data Source
AI summary
A flexible system capable of utilizing data from different monitoring techniques and capable of providing assistance to patients with diabetes at several scalable levels, ranging from advice about long-term trends and prognosis to real-time automated closed-loop control (artificial pancreas). These scalable monitoring and treatment strategies are delivered by a unified system called the Diabetes Assistant (DiAs) platform. The system provides a foundation for implementation of various monitoring, advisory, and automated diabetes treatment algorithms or methods. The DiAs recommendations are tailored to the specifics of an individual patient, and to the patient risk assessment at any given moment. A central data exchange node or server collects patient data from individual DiAs devices and provides safety assurance, monitoring, telemedicine and database building for the DiAs system.